Revision as of 12:49, 24 September 2021 editOzzie10aaaa (talk | contribs)Autopatrolled, Extended confirmed users, New page reviewers213,762 editsNo edit summary← Previous edit | Latest revision as of 16:53, 28 October 2024 edit undoAnomieBOT (talk | contribs)Bots6,576,465 editsm Dating maintenance tags: {{Cn}} | ||
(17 intermediate revisions by 8 users not shown) | |||
Line 21: | Line 21: | ||
| deaths = | | deaths = | ||
}} | }} | ||
'''ICF syndrome''' (or '''I'''mmunodeficiency, '''C'''entromere instability and '''F'''acial anomalies '''syndrome''')<ref>{{OMIM|242860}}</ref> is a very rare ] ]<ref name="pmid7557962">{{ |
'''ICF syndrome''' (or '''I'''mmunodeficiency, '''C'''entromere instability and '''F'''acial anomalies '''syndrome''')<ref>{{OMIM|242860}}</ref> is a very rare ] ]<ref name="pmid7557962">{{Cite journal |last=Brown, Dc |last2=Grace, E |last3=Sumner, At |last4=Edmunds, At |last5=Ellis, Pm |date=October 1995 |title=ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome |journal=Human Genetics |volume=96 |issue=4 |pages=411–6 |doi=10.1007/BF00191798 |pmid=7557962 |s2cid=1459435}}</ref> ]. | ||
==Presentation== | ==Presentation== | ||
It is characterized by variable reductions in ] ] levels which cause most ICF patients to succumb to ]s before ]. ICF syndrome patients exhibit ] which include ], ], ]s and ]. | It is characterized by variable reductions in ] ] (IgG, IgM and/or IgA) levels which cause most ICF patients to succumb to ]s before ]. ICF syndrome patients exhibit ] which include ], ], ]s and ].<ref name="Orphanet">{{Cite journal |last=Ehrlich |first=Melanie |last2=Jackson |first2=Kelly |last3=Weemaes |first3=Corry |date=1 March 2006 |title=Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF) |journal=Orphanet Journal of Rare Diseases |volume=1 |issue=1 |pages=2 |doi=10.1186/1750-1172-1-2 |issn=1750-1172 |pmc=1459120 |pmid=16722602 |doi-access=free}}</ref> Other frequent symptoms observed in individuals with ICF syndrome include intellectual disability, recurrent and prolonged respiratory infections, and integumentary and digestive system infections.<ref>{{Cite web |title=IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1 |url=https://www.omim.org/entry/242860 |access-date=13 February 2023 |website=OMIM}}</ref> | ||
==Genetics== | ==Genetics== | ||
Mutations in four ]s can cause this syndrome:<ref name=Ren2019>Ren R, Hardikar S, Horton JR, Lu Y, Zeng Y, Singh AK, Lin K, Coletta LD, Shen J, Lin Kong CS, Hashimoto H, Zhang X, Chen T, Cheng X (2019) Structural basis of specific DNA binding by the transcription factor ZBTB24. Nucleic Acids Res |
Mutations in four ]s can cause this syndrome:<ref name="Ren2019">Ren R, Hardikar S, Horton JR, Lu Y, Zeng Y, Singh AK, Lin K, Coletta LD, Shen J, Lin Kong CS, Hashimoto H, Zhang X, Chen T, Cheng X (2019) Structural basis of specific DNA binding by the transcription factor ZBTB24. Nucleic Acids Res</ref> Cell division cycle associated protein 7 (]), DNA-methyltransferase 3b (]), Lymphoid specific helicase (]) and Zinc finger- and BTB domain containing protein 24 (]).{{cn|date=October 2024}} | ||
The CDCA7 gene is located on ] (2q31.1). | The CDCA7 gene is located on ] (2q31.1).{{cn|date=October 2024}} | ||
The DNMT3B gene is located on ] (20q11.2)).<ref name="pmid15580563">{{ |
The DNMT3B gene is located on ] (20q11.2)).<ref name="pmid15580563">{{Cite journal |last=Jiang, Yl |last2=Rigolet, M |last3=Bourc'His, D |last4=Nigon, F |last5=Bokesoy, I |last6=Fryns, Jp |last7=Hultén, M |last8=Jonveaux, P |last9=Maraschio, P |last10=Mégarbané, A |last11=Moncla, A |last12=Viegas-Péquignot, E |date=January 2005 |title=DNMT3B mutations and DNA methylation defect define two types of ICF syndrome |journal=Human Mutation |volume=25 |issue=1 |pages=56–63 |doi=10.1002/humu.20113 |pmid=15580563 |s2cid=41614913}}</ref><ref>{{OMIM|602900}}</ref> | ||
The HELLS gene is located on ] (10q23.33) | The HELLS gene is located on ] (10q23.33){{cn|date=October 2024}} | ||
The ZBTB24 gene is located on ] (6q21) | The ZBTB24 gene is located on ] (6q21){{cn|date=October 2024}} | ||
This disease is inherited in an autosomal ] manner.<ref name="pmid7557962"/> | This disease is inherited in an autosomal ] manner.<ref name="pmid7557962" /> | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis can occur using a ] or linkage analysis or DNA sequence analysis. This can occur prior to birth in families with a known history of the condition. <ref name="Orphanet" /> | |||
{{Empty section|date=July 2017}} | |||
==Treatment== | ==Treatment== | ||
For ICF patients the most diffused therapy consists of repeated intravenous infusions of immunoglobulins for the patients entire lifespan. In 2007, Gennery et al. cured the humoral and cellular immunological defect in three ICF1 patients by hematopoietic stem cell transplantation (HSCT). The only side effect was related to the development of autoimmune phenomena in two of them.<ref>{{ |
For ICF patients the most diffused therapy consists of repeated intravenous infusions of immunoglobulins for the patients entire lifespan. In 2007, Gennery et al. cured the humoral and cellular immunological defect in three ICF1 patients by hematopoietic stem cell transplantation (HSCT). The only side effect was related to the development of autoimmune phenomena in two of them.<ref>{{Cite journal |last=Gennery |first=A. R. |last2=Slatter |first2=M. A. |last3=Bredius |first3=R. G. |last4=Hagleitner |first4=M. M. |last5=Weemaes |first5=C. |last6=Cant |first6=A. J. |last7=Lankester |first7=A. C. |year=2007 |title=Hematopoietic Stem Cell Transplantation Corrects the Immunologic Abnormalities Associated with Immunodeficiency Centromeric Instability Facial Dysmorphism Syndrome |journal=Pediatrics |volume=120 |issue=5 |pages=e1341–e1344 |doi=10.1542/peds.2007-0640 |pmid=17908720 |s2cid=11910398}}</ref> This is the only documented case of restoring the immune conditions and growth improvement in these patients.<ref>https://www.ptglab.com/news/blog/icf-syndrome-a-gene-silencing-chromatin-disorder/ IFC Syndrome: A gene silencing chromatin disorder</ref> | ||
== See also == | == See also == | ||
Line 74: | Line 75: | ||
] | ] | ||
] | ] | ||
{{immunology-stub}} | |||
{{Genetic-disorder-stub}} |
Latest revision as of 16:53, 28 October 2024
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Immunodeficiency–centromeric instability–facial anomalies syndrome" – news · newspapers · books · scholar · JSTOR (August 2020) (Learn how and when to remove this message) |
ICF syndrome | |
---|---|
Other names | Immunodeficiency-centromeric instability-facial anomalies syndrome |
ICF syndrome (or Immunodeficiency, Centromere instability and Facial anomalies syndrome) is a very rare autosomal recessive immune disorder.
Presentation
It is characterized by variable reductions in serum immunoglobulin (IgG, IgM and/or IgA) levels which cause most ICF patients to succumb to infectious diseases before adulthood. ICF syndrome patients exhibit facial anomalies which include hypertelorism, low-set ears, epicanthal folds and macroglossia. Other frequent symptoms observed in individuals with ICF syndrome include intellectual disability, recurrent and prolonged respiratory infections, and integumentary and digestive system infections.
Genetics
Mutations in four genes can cause this syndrome: Cell division cycle associated protein 7 (CDCA7), DNA-methyltransferase 3b (DNMT3B), Lymphoid specific helicase (HELLS) and Zinc finger- and BTB domain containing protein 24 (ZBTB24).
The CDCA7 gene is located on chromosome 2 (2q31.1).
The DNMT3B gene is located on chromosome 20 (20q11.2)).
The HELLS gene is located on chromosome 10 (10q23.33)
The ZBTB24 gene is located on chromosome 6 (6q21)
This disease is inherited in an autosomal recessive manner.
Diagnosis
Diagnosis can occur using a karyotype or linkage analysis or DNA sequence analysis. This can occur prior to birth in families with a known history of the condition.
Treatment
For ICF patients the most diffused therapy consists of repeated intravenous infusions of immunoglobulins for the patients entire lifespan. In 2007, Gennery et al. cured the humoral and cellular immunological defect in three ICF1 patients by hematopoietic stem cell transplantation (HSCT). The only side effect was related to the development of autoimmune phenomena in two of them. This is the only documented case of restoring the immune conditions and growth improvement in these patients.
See also
References
- Online Mendelian Inheritance in Man (OMIM): 242860
- ^ Brown, Dc; Grace, E; Sumner, At; Edmunds, At; Ellis, Pm (October 1995). "ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome". Human Genetics. 96 (4): 411–6. doi:10.1007/BF00191798. PMID 7557962. S2CID 1459435.
- ^ Ehrlich, Melanie; Jackson, Kelly; Weemaes, Corry (1 March 2006). "Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF)". Orphanet Journal of Rare Diseases. 1 (1): 2. doi:10.1186/1750-1172-1-2. ISSN 1750-1172. PMC 1459120. PMID 16722602.
- "IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1; ICF1". OMIM. Retrieved 13 February 2023.
- Ren R, Hardikar S, Horton JR, Lu Y, Zeng Y, Singh AK, Lin K, Coletta LD, Shen J, Lin Kong CS, Hashimoto H, Zhang X, Chen T, Cheng X (2019) Structural basis of specific DNA binding by the transcription factor ZBTB24. Nucleic Acids Res
- Jiang, Yl; Rigolet, M; Bourc'His, D; Nigon, F; Bokesoy, I; Fryns, Jp; Hultén, M; Jonveaux, P; Maraschio, P; Mégarbané, A; Moncla, A; Viegas-Péquignot, E (January 2005). "DNMT3B mutations and DNA methylation defect define two types of ICF syndrome". Human Mutation. 25 (1): 56–63. doi:10.1002/humu.20113. PMID 15580563. S2CID 41614913.
- Online Mendelian Inheritance in Man (OMIM): 602900
- Gennery, A. R.; Slatter, M. A.; Bredius, R. G.; Hagleitner, M. M.; Weemaes, C.; Cant, A. J.; Lankester, A. C. (2007). "Hematopoietic Stem Cell Transplantation Corrects the Immunologic Abnormalities Associated with Immunodeficiency Centromeric Instability Facial Dysmorphism Syndrome". Pediatrics. 120 (5): e1341 – e1344. doi:10.1542/peds.2007-0640. PMID 17908720. S2CID 11910398.
- https://www.ptglab.com/news/blog/icf-syndrome-a-gene-silencing-chromatin-disorder/ IFC Syndrome: A gene silencing chromatin disorder
External links
Classification | D |
---|---|
External resources |
Lymphoid and complement disorders causing immunodeficiency | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary |
| ||||||||||||
Acquired | |||||||||||||
Leukopenia: Lymphocytopenia | |||||||||||||
Complement deficiency |